Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson’s disease

Title:	The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson’s disease
Authors:	Werner, M. H.^{Aff1, IDs43587026010844_cor1}; McGarry, A.^{Aff2, Aff3}; Meyer, C.^Aff1; Mancino, E.^Aff4; Klint, C.^Aff4; Pellecchia, J.^Aff4; Kieburtz, K.^Aff2; Levine, T.^Aff5; Bellaire, B.^Aff5; Gibbons, C.^{Aff5, Aff6}; Freeman, R.^Aff5; Ellenbogen, A.^Aff7; Klos, K.^Aff8; Ospina, M.^Aff9; Hauser, R. A.^Aff10; Shannon, K.^Aff11; Asaad, H.^Aff12; Park, A.^Aff13; McAllister, P.^Aff14; Isaacson, S. H.^Aff15; LeDoux, M. S.^Aff16; Dhall, R.^Aff17; Shpiner, D.^Aff18; Charles, P.^Aff19; Agarwal, P.^Aff20; Peckham, E.^Aff21; Mazzeo, P.^Aff22; Davis, M.^Aff23; Pahwa, R.^Aff24; Brodsky, M.^Aff25; Lew, M.^Aff26; Purino, L.^Aff27; Mantri, S.^Aff28; Parashos, S.^Aff29; Justiz, W.^Aff30; Chachar, M.^Aff31; Robottom, B.^Aff32; Budman, E.^Aff33; Blindauer, K.^Aff34; Bellows, S.^Aff35; Goudreau, J.^Aff36; Steen, S.^Aff37; Olanow, C. W.^{Aff2, Aff38}
Source:	Nature Aging. 6(3):626-635
Database:	Springer Nature Journals